Defunct Company
Total Trials
12
As Lead Sponsor
1
As Collaborator
11
Total Enrollment
15,267
NCT01450449
Short Course vs. Standard Course Radiotherapy in Elderly and/or Frail Patients With Glioblastoma Multiforme
Phase: Phase 3
Role: Collaborator
Start: Feb 28, 2009
Completion: Nov 30, 2014
NCT02819609
Comparing Patient-Centered Outcomes After Treatment for Uterine Fibroids
Phase: N/A
Start: Nov 30, 2014
Completion: Jan 31, 2015
NCT03085446
Insomnia in Older Adults: Impact of Personalized, Diet-Induced Alterations in the Microbiota
Start: Feb 1, 2017
Completion: May 1, 2020
NCT03256929
Personalized Diet-driven Microbiota Alterations as a Tool for Improving Mood Status in Elderly
Start: Sep 11, 2017
Completion: Feb 1, 2021
NCT03360578
Measuring Physiology to Determine if Pre-panic Attack Detection is Possible
Role: Lead Sponsor
Start: Oct 1, 2018
Completion: Dec 31, 2022
NCT05358873
Efficacy and Safety of Nasal Spray Solution Containing Human IgG1 Anti-COVID-19 Antibody Cocktail
Start: Apr 20, 2022
Completion: Jul 1, 2022
NCT05743283
Efficacy of SynEx Wound Rinse in Civilian Surrogates of Combat Injury Wounds
Start: Apr 12, 2023
Completion: Sep 30, 2025
NCT05996029
A Joint Real-World Study of Digital Smoking Cessation Interventions
Start: Aug 31, 2023
Completion: Jun 30, 2024
NCT06080555
Bioequivalence Study of Ferric Carboxymaltose Injection in Participants With Iron Deficiency Anaemia
Phase: Phase 1
Start: Oct 9, 2023
Completion: Mar 22, 2024
NCT06341868
Dynamic Muscular Electrical Stimulation Following Anterior Cruciate Ligament Reconstruction in Military Academy Cadets
Start: Sep 19, 2024
Completion: Sep 30, 2026
NCT06895993
Bioequivalence Study of Ferric Carboxymaltose Injection in Healthy Chinese Participants
Start: Apr 7, 2025
Completion: May 8, 2025